BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mcpherson ML, Walker KA, Davis MP, Bruera E, Reddy A, Paice J, Malotte K, Lockman DK, Wellman C, Salpeter S, Bemben NM, Ray JB, Lapointe BJ, Chou R. Safe and Appropriate Use of Methadone in Hospice and Palliative Care: Expert Consensus White Paper. Journal of Pain and Symptom Management 2019;57:635-645.e4. [DOI: 10.1016/j.jpainsymman.2018.12.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Fenton C, Lyseng-williamson KA. Methadone is an option to treat cancer pain in carefully selected patients. Drugs Ther Perspect 2020;36:502-8. [DOI: 10.1007/s40267-020-00772-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Mammana G, Bertolino M, Bruera E, Orellana F, Vega F, Peirano G, Bunge S, Armesto A, Dran G. First-line methadone for cancer pain: titration time analysis. Support Care Cancer 2021;29:6335-41. [PMID: 33880639 DOI: 10.1007/s00520-021-06211-y] [Reference Citation Analysis]
3 Heung Y, Reddy A. How to Use Methadone in an Era of an Opioid Epidemic. Curr Treat Options Oncol 2020;21:30. [PMID: 32193644 DOI: 10.1007/s11864-020-0724-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Edmonds KP, Saunders IM, Willeford A, Ajayi TA, Atayee RS. Emerging Challenges to the Safe and Effective Use of Methadone for Cancer-Related Pain in Paediatric and Adult Patient Populations. Drugs 2020;80:115-30. [PMID: 31820362 DOI: 10.1007/s40265-019-01234-6] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Haas MF, Latchman J, Guastella AM, Craig DS, Chang YD. Lucid Dreams Associated with Pregabalin: Implications for Clinical Practice. J Pain Palliat Care Pharmacother 2022;:1-6. [PMID: 35759531 DOI: 10.1080/15360288.2022.2081754] [Reference Citation Analysis]
6 Willeford A, Atayee RS, Winters KD, Mesarwi P. The Enigma of Low-Dose Ketamine for Treatment of Opioid-Induced Hyperalgesia in the Setting of Psychosocial Suffering and Cancer-Associated Pain. Journal of Pain & Palliative Care Pharmacotherapy 2019;32:248-55. [DOI: 10.1080/15360288.2019.1615028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Okayama S, Matsuda Y. Assistance of a Palliative Care Certified Nurse in the Alleviation of Refractory Cancer Pain by Switching Opioids to Oral Methadone in a Japanese Outpatient Setting. J Hosp Palliat Nurs 2021;23:539-43. [PMID: 34334770 DOI: 10.1097/NJH.0000000000000790] [Reference Citation Analysis]
8 Hanna V, Senderovich H. Methadone in Pain Management: A Systematic Review. The Journal of Pain 2021;22:233-45. [DOI: 10.1016/j.jpain.2020.04.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
9 Irwin MN, Ellingrod VL, Smith MA. Pharmacogenetics of Methadone for Pain Management in Palliative Care. J Pain Symptom Manage 2021:S0885-3924(21)00519-4. [PMID: 34461232 DOI: 10.1016/j.jpainsymman.2021.08.007] [Reference Citation Analysis]
10 Smith MA, Quirk KC, Saul DC, Rodgers PE, Silveira MJ. Comparing Methadone Rotation to Consensus Opinion. J Pain Symptom Manage 2020;59:116-20. [PMID: 31560968 DOI: 10.1016/j.jpainsymman.2019.09.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kreutzwiser D, Tawfic QA. Methadone for Pain Management: A Pharmacotherapeutic Review. CNS Drugs 2020;34:827-39. [DOI: 10.1007/s40263-020-00743-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Datta P, Kruk JS, Jordan K, Fisher KA. Dying with dignity: the challenges of end-of-life care in patients with substance use disorders. BMJ Case Rep 2021;14:e240945. [PMID: 34815225 DOI: 10.1136/bcr-2020-240945] [Reference Citation Analysis]
13 Madden K, Jo E, Williams JL, Liu D, Bruera E. Corrected QT Interval Prolongation in Pediatric and Young Adult Patients on Methadone for Cancer-Related Pain. J Pain Symptom Manage 2019;58:678-84. [PMID: 31195079 DOI: 10.1016/j.jpainsymman.2019.05.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
14 Dziedzic KL, Albert RH. Management of Intractable Symptoms in Oncologic Care. Curr Oncol Rep 2021;23:93. [PMID: 34125305 DOI: 10.1007/s11912-021-01082-2] [Reference Citation Analysis]
15 Liu J, Smith KE, Riker RR, Craig WY, McKelvy DJ, Kemp HD, Nichols SD, Fraser GL. Methadone bioavailability and dose conversion implications with intravenous and enteral administration: A scoping review. Am J Health Syst Pharm 2021;78:1395-401. [PMID: 33872344 DOI: 10.1093/ajhp/zxab166] [Reference Citation Analysis]
16 Ramkiran S, Thota RS. Methadone in Cancer Pain. Indian J Palliat Care 2020;26:215-20. [PMID: 32874036 DOI: 10.4103/0973-1075.285690] [Reference Citation Analysis]
17 Biewald MA, Scarborough B, Lindenberger E. Methadone for Palliative Care Providers: A Case-Based Flipped Classroom Module for Faculty and Fellows. MedEdPORTAL 2021;17:11172. [PMID: 34395853 DOI: 10.15766/mep_2374-8265.11172] [Reference Citation Analysis]